CAR T cells: Recent Cell Based Therapy for Cancer

One of the main causes of death in the globe is cancer. Numerous traditional cytotoxic methods for treating neoplastic illnesses have been developed over the years. However, due to their limited efficacy in light of the heterogeneity of cancer cells, there is a continuing quest for therapeutic strategies that provide better results, such as immunotherapy, which makes use of and boosts the immune system's normal functioning (1,2,3). Certain cancers are treated with chimeric antigen receptor (CAR) T-cell therapy, which modifies T-lymphocytes or T-cells to make them more effective cancer-fighting cells. While long-term data are still being gathered, CAR T-cell therapy is showing to be a very successful method of treating some blood cancers (4). Chimeric antigen receptor (CAR)-T cell therapy is among the newest and most effective treatments for blood cancer. In order to combat cancer, these treatments rely on your body's immune system (5).